Y0001287
Heparin calcium for NMR identification
European Pharmacopoeia (EP) Reference Standard
Synonym(s):
Heparin calcium salt
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
grade
pharmaceutical primary standard
API family
heparin
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
Looking for similar products? Visit Product Comparison Guide
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Heparin calcium for NMR identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Other Notes
Sales restrictions may apply.
related product
Product No.
Description
Pricing
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Sorry, we don't have COAs for this product available online at this time.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Cutaneous allergic reaction to heparins: subcutaneous but not intravenous provocation.
Maria Maroto-Iitani et al.
Contact dermatitis, 52(4), 228-230 (2005-04-30)
Maria Laura Cossu et al.
Chirurgia italiana, 59(3), 331-335 (2007-08-01)
Patients with morbid obesity who undergo bariatric surgery are usually considered at high risk of developing venous thromboembolism. Considering that deep vein thrombosis is often asymptomatic, primary prevention is the key to reducing morbidity and mortality. Between 1995 and 2003
F Perfetto et al.
Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna, 16(3), 179-184 (2001-11-06)
An 80-year-old woman was admitted to the Traumatologic Hospital of Florence because of bilateral post-traumatic humeral fractures. Subcutaneous calcium heparin was immediately administered to prevent deep venous thrombosis. Nine days later, the patient was referred to the Internal Medicine Unit
M Ferro et al.
Heart disease (Hagerstown, Md.), 2(4), 278-281 (2001-12-01)
This study compares the prophylactic effectiveness of calcium heparin (CH) with that of acetylsalicylic acid (ASA) in the long-term anticoagulant management of patients with myocardial infarct. Forty-four patients discharged from a coronary care unit after acute myocardial infarction were randomly
[Lack of clinical evidence and variety of practice in the treatment of venous thrombosis in kidney transplants].
G Raynal
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 19(3), 191-192 (2009-03-10)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service